Results 31 to 40 of about 10,552 (197)

Sarna Norueguesa

open access: yesActa Médica Portuguesa, 2013
Hugo Barreiros   +2 more
doaj   +2 more sources

Intratumoral electroporation of a self-amplifying RNA expressing IL-12 induces antitumor effects in mouse models of cancer

open access: yesMolecular Therapy: Nucleic Acids, 2022
Alphavirus vectors based on self-amplifying RNA (saRNA) generate high and transient levels of transgene expression and induce innate immune responses, making them an interesting tool for antitumor therapy.
Noelia Silva-Pilipich   +5 more
doaj   +1 more source

Immunogenicity of stabilized HIV-1 Env trimers delivered by self-amplifying mRNA

open access: yesMolecular Therapy: Nucleic Acids, 2021
Self-amplifying mRNA (saRNA) represents a promising platform for nucleic acid delivery of vaccine immunogens. Unlike plasmid DNA, saRNA does not require entry into the nucleus of target cells for expression, having the capacity to drive higher protein ...
Yoann Aldon   +11 more
doaj   +1 more source

Progress in researches on self-amplifying RNA vaccines

open access: yesZhongguo gonggong weisheng, 2023
Self-amplifying RNA (saRNA) vaccines are a new generation of mRNA vaccines. In addition to containing mRNA sequences encoding antigen proteins, saRNA vaccines also have unique self-amplifying elements, so self-amplification of antigen sequences can be ...
Shuo WANG, Jianmin LI
doaj   +1 more source

Enhanced immune responses following heterologous vaccination with self-amplifying RNA and mRNA COVID-19 vaccines.

open access: yesPLoS Pathogens, 2022
The optimal vaccination strategy to boost responses in the context of pre-existing immune memory to the SARS-CoV-2 spike (S) glycoprotein is an important question for global public health.
Tamara Elliott   +13 more
doaj   +1 more source

saRNA vaccine expressing membrane-anchored RBD elicits broad and durable immunity against SARS-CoV-2 variants of concern

open access: yesNature Communications, 2023
Several vaccines have been widely used to counteract the global pandemic caused by SARS-CoV-2. However, due to the rapid emergence of SARS-CoV-2 variants of concern (VOCs), further development of vaccines that confer broad and longer-lasting protection ...
M. Komori   +17 more
semanticscholar   +1 more source

Poly(2-oxazoline)/saRNA Polyplexes for Targeted and Nonviral Gene Delivery

open access: yesBiomacromolecules, 2023
RNA delivery has been demonstrated to be a potent method of vaccine delivery, as demonstrated by the recent success of the COVID-19 vaccines. Polymers have been shown to be effective vehicles for RNA delivery, with poly(ethylene imine) (PEI) being the ...
G. Hayes   +4 more
semanticscholar   +1 more source

RNA Activation—A Novel Approach to Therapeutically Upregulate Gene Transcription

open access: yesMolecules, 2021
RNA activation (RNAa) is a mechanism whereby RNA oligos complementary to genomic sequences around the promoter region of genes increase the transcription output of their target gene.
Choon Ping Tan   +4 more
doaj   +1 more source

C/EBPα Short-Activating RNA Suppresses Metastasis of Hepatocellular Carcinoma through Inhibiting EGFR/β-Catenin Signaling Mediated EMT. [PDF]

open access: yesPLoS ONE, 2016
Hepatocellular carcinoma is associated with high mortality, and tumor metastasis is an important reason for poor prognosis. However, metastasis has not been effectively prevented in clinical therapy and the mechanisms underlying metastasis have not been ...
Hongbo Huan   +7 more
doaj   +1 more source

Sarna Noruega

open access: yesRevista médica (Colegio de Médicos y Cirujanos de Guatemala), 2020
La sarna noruega es una forma aguda de la sarna que se observa en pacientes inmunosupresos. A continuación se presenta el caso de un paciente de 73 años con antecedente de insuficiencia renal con diagnóstico de sarna noruega.
Rosmin Del Pilar Marroquín Remón   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy